New York State Common Retirement Fund Portage Biotech Inc. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$5.16 - $11.95 $20,124 - $46,605	-3,900 Reduced 98.83%	46 $0
Q1 2022 May 05, 2022	SELL	$6.57 - $12.0 $45 - $84	-7 Reduced 0.18%	3,946 $26,000
Q4 2021 Feb 02, 2022	BUY	$10.73 - $23.74 $203 - $451	19 Added 0.48%	3,953 $42,000
Q3 2021 Nov 02, 2021	BUY	$13.65 - $22.4 $464 - $761	34 Added 0.87%	3,934 $80,000
Q2 2021 Aug 02, 2021	BUY	$20.96 - $42.81 $81,744 - $166,959	3,900 New	3,900 $82,000

28.4K

Ticker PRTG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,943,700
Market Cap $69.5M
Description
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.